Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
20.44
+0.68 (3.44%)
At close: May 29, 2026, 4:00 PM EDT
20.40
-0.04 (-0.20%)
After-hours: May 29, 2026, 7:00 PM EDT
Alamar Biosciences Revenue
Alamar Biosciences had revenue of $26.04M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $87.16M. In the year 2025, Alamar Biosciences had annual revenue of $74.21M with 195.17% growth.
Revenue (ttm)
$87.16M
Revenue Growth
+195.17%
P/S Ratio
16.26
Revenue / Employee
$392,590
Employees
222
Market Cap
1.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.21M | 49.07M | 195.17% |
| Dec 31, 2024 | 25.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALMR News
- 18 days ago - Alamar Biosciences Slides: FY 2026 - Filings
- 18 days ago - Alamar Biosciences initiated with an Outperform at Leerink - TheFly
- 18 days ago - Alamar Biosciences initiated with a Neutral at BofA - TheFly
- 18 days ago - Alamar Biosciences initiated with a Buy at TD Cowen - TheFly
- 18 days ago - Alamar Biosciences initiated with an Overweight at JPMorgan - TheFly
- 18 days ago - Alamar Biosciences initiated with a Buy at Stifel - TheFly
- 22 days ago - Alamar Biosciences reports Q1 EPS ($1.74) vs. (68c) last year - TheFly
- 22 days ago - Alamar Biosciences Earnings release: Q1 2026 - Filings